Combination of G2-S16 dendrimer/dapivirine antiretroviral as a new HIV-1 microbicide

To research the synergistic activity of G2-S16 dendrimer and dapivirine (DPV) antiretroviral as microbicide candidate to prevent HIV-1 infection. We assess the toxicity of DPV on cell lines by MTT assay, the anti-HIV-1 activity of G2-S16 and DPV alone or combined at several fixed ratios. Finally, their ability to inhibit the bacterial growth was assayed. The analysis of combinatorial effects and the effective concentrations were performed with CalcuSyn software. Our results represent the first proof-of-concept study of G2-S16/DPV combination to develop a safe microbicide.